PLx Pharma Inc. PLXP
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.53M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.08
- Beta
- 3.92
- Short ratio
- 0.83
- Inst. own
- 23.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 12, 2023
- 50-d avg
- 0.136178
- 200-d avg
- 0.558388
- 1y target
- 0.00
5D chart
Chart tools
Chart is warming up
The five-day price history for PLXP has not been loaded yet. Try again in a moment.
Altman Z-Score
-9.07 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -3.7×
P/S 23.1×
P/B 3.7×
P/FCF -5.9×
EV/EBITDA -2.6×
EV/Sales 14.6×
FCF Yield -17.0%
Gross Margin 41.5%
Operating Margin -497.0%
Net Margin -626.9%
ROE -99.6%
ROIC -63.0%
ROA -67.1%
Revenue 26873.4%
Operating Income -203.1%
EPS (diluted) -40.6%
Free Cash Flow -160.2%
Current Ratio 6.2×
Quick Ratio 6.0×
Debt / Equity 0.0×
Net Debt / EBITDA 1.5×
Interest Coverage -40790×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2021-12-31